The Wall Street Journal is reporting that EC antitrust investigators are widening its probe of the pharmaceutical industry, looking at possible unfair tactics that block competition and prop up prices.
The Wall Street Journal is reporting that EC antitrust investigators are widening its probe of the pharmaceutical industry, looking at possible unfair tactics that block competition and prop up prices.